All In Biotech

Drug Trial Radar · NCT06277934

A Study of RGT001-075 in Participants With Obesity or Overweight With Weight-Related Comorbidities

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of RGT001-075 Compared With Placebo in Adult Patients With Obesity or Overweight With Weight-Related Comorbidities

Last checked: Nov 20, 2026Latest source record: Aug 7, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

73

Actual

Start

Mar 8, 2024

Primary completion

Aug 13, 2024

Study completion Aug 13, 2024

Sponsor

Lead sponsor
Regor Pharmaceuticals Inc.Industry
Sponsor type
Industry
First posted
Feb 26, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study was to evaluate the safety and tolerability of RGT001-075 in healthy participants with obesity

Conditions

  • Obesity

Interventions

  • RGT001-075Drug

    Administered orally

  • PlaceboDrug

    Administered orally

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of participants with Treatment-emergent Adverse Event(AE) by severity/Serious Adverse Event (SAE), with Clinical Laboratory Abnormalities, Clinically Significant Change From Baseline in Vital Signs and Abnormal Electrocardiogram(ECG) readingsTime frame: 14 weeks

Locations

10 sites in 1 country. Site status is shown where the registry gives one.

  • Velocity Clinical Research

    Los Angeles, California

  • Velocity Clinical Research

    Valparaiso, Indiana

  • Velocity Clinical Research

    Omaha, Nebraska

  • Velocity Clinical Research

    Vestal, New York

  • Velocity Clinical Research

    Durham, North Carolina

  • Velocity Clinical Research

    Cleveland, Ohio

  • Velocity Clinical Research

    Medford, Oregon

  • Velocity Clinical Research

    East Greenwich, Rhode Island

  • Velocity Clinical Research

    Dallas, Texas

  • Velocity Clinical Research

    West Jordan, Utah

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.